Home LiteratureArticle Details
PMID: 15194752 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.

Journal of virology ·Vol. 78 ·No. 13 ·2004-07-00 ·Pages 6775-85

Yuste E, Reeves JD, Doms RW, Desrosiers RC

Abstract

Specific mutations were created in the cytoplasmic domain of the gp41 transmembrane protein of simian immunodeficiency virus strain 239 (SIV239). The resultant strains included a mutant in which Env residue 767 was changed to a stop codon, a double mutant in which positions 738 and 739 were changed to stop codons, another mutant in which a prominent endocytosis motif was changed from YRPV to GRPV by the substitution of tyrosine 721, and a final combination mutant bearing Q738stop, Q739stop, and Y721G mutations. The effects of these mutations on cell surface expression, on Env incorporation into virions, and on viral infectivity were examined. The molar ratio of Gag to gp120 of 54:1 that we report here for SIV239 virions agrees very well with the ratio of 60:1 reported previously by Chertova et al. (E. Chertova, J. W. Bess, Jr., B. J. Crise, R. C. Sowder II, T. M. Schaden, J. M. Hilburn, J. A. Hoxie, R. E. Benveniste, J. D. Lifson, L. E. Henderson, and L. O. Arthur, J. Virol. 76:5315-5325, 2002), although they were determined by very different methodologies. Assuming 1,200 to 2,500 Gag molecules per virion, this corresponds to 7 to 16 Env trimers per SIV239 virion particle. Although all of the mutations increased Env levels in virions, E767stop had the most dramatic effect, increasing the Env content per virion 25- to 50-fold. Increased levels of Env content in virions correlated strictly with higher levels of Env expression on the cell surface. The increased Env content with the E767stop mutation also correlated with an increased infectivity, but the degree of change was not proportional: the 25- to 50-fold increase in Env content only increased infectivity 2- to 3-fold. All of the mutants replicated efficiently in the CEMx174 and Rh221-89 cell lines. Although some of these findings have been reported previously, our findings show that the effects of the cytoplasmic domain of gp41 on the Env content in virions can be dramatic, that the Env content in virions correlates strictly with the levels of cell surface expression, and that the Env content in virions can determine infectivity; furthermore, our results define a particular change with the most dramatic effects.

MeSH Terms
Animals Cell Line Cell Membrane/metabolism Humans Membrane Glycoproteins/genetics,metabolism Mutagenesis, Site-Directed Mutation Retroviridae Proteins/genetics,metabolism Simian Immunodeficiency Virus/genetics,metabolism,pathogenicity Virion/metabolism,pathogenicity
Chemicals
Membrane Glycoproteins Retroviridae Proteins SIV envelope protein gp41
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Yuste Eloísa
New England Primate Research Center, Harvard Medical School, Southborough, MA 01772-9102, USA.
Reeves Jacqueline D
Doms Robert W
Desrosiers Ronald C
References (58)
58 references, click to expand
  1. Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry.
    AIDS Res Hum Retroviruses. 2001 Nov 20;17(17):1615-24 PMID: 11779349
  2. The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin.
    Mol Cells. 1999 Jun 30;9(3):281-5 PMID: 10420987
  3. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
    J Virol. 2002 Apr;76(7):3338-49 PMID: 11884559
  4. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    J Virol. 2002 Jun;76(11):5315-25 PMID: 11991960
  5. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.
    J Virol. 2002 Aug;76(15):7863-7 PMID: 12097599
  6. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54 PMID: 12444251
  7. Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.
    J Virol. 2003 Jan;77(1):375-81 PMID: 12477842
  8. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.
    J Virol. 2003 Jun;77(12):6931-45 PMID: 12768012
  9. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7 PMID: 14668432
  10. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  11. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.
    Nature. 1987 Aug 6-12;328(6130):543-7 PMID: 3649576
  12. The organization of the envelope projections on the surface of HIV.
    Arch Virol. 1988;100(3-4):255-66 PMID: 3401118
  13. Electron microscopy of human immunodeficiency virus.
    J Gen Virol. 1988 Oct;69 ( Pt 10):2455-69 PMID: 2459300
  14. The morphology of simian immunodeficiency virus as shown by negative staining electron microscopy.
    J Gen Virol. 1989 Aug;70 ( Pt 8):2215-9 PMID: 2475583
  15. Significance of premature stop codons in env of simian immunodeficiency virus.
    J Virol. 1989 Nov;63(11):4709-14 PMID: 2795718
  16. SIV adaptation to human cells.
    Nature. 1989 Oct 19;341(6243):573-4 PMID: 2677749
  17. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
    Science. 1990 Jun 1;248(4959):1109-12 PMID: 2160735
  18. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1990 Nov;6(11):1221-31 PMID: 2078405
  19. Assembly and morphology of HIV: potential effect of structure on viral function.
    AIDS. 1991 Jun;5(6):617-37 PMID: 1652977
  20. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51 PMID: 1380261
  21. Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates.
    J Med Primatol. 1992 Jul;21(5):265-9 PMID: 1383547
  22. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
    J Virol. 1992 Nov;66(11):6616-25 PMID: 1357190
  23. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  24. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.
    J Virol. 1993 May;67(5):2824-31 PMID: 8474176
  25. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells.
    J Virol. 1993 Jun;67(6):3077-86 PMID: 8497044
  26. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
    Virology. 1993 Jul;195(1):167-74 PMID: 8317093
  27. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
    Virology. 1993 Nov;197(1):255-64 PMID: 8212561
  28. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
    J Biol Chem. 1993 Oct 25;268(30):22895-9 PMID: 8226798
  29. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Virology. 1994 Aug 15;203(1):8-19 PMID: 8030287
  30. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
    J Virol. 1995 Mar;69(3):1984-9 PMID: 7853546
  31. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
    J Virol. 1995 Jun;69(6):3824-30 PMID: 7745730
  32. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
    J Immunol. 1995 Jul 1;155(1):473-88 PMID: 7602119
  33. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.
    J Virol. 1995 Sep;69(9):5217-27 PMID: 7636963
  34. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    J Virol. 1996 Jan;70(1):341-51 PMID: 8523546
  35. An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface.
    J Cell Biol. 1996 Mar;132(5):795-811 PMID: 8603913
  36. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain.
    AIDS Res Hum Retroviruses. 1997 Apr 10;13(6):441-7 PMID: 9100985
  37. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.
    J Virol. 1997 Aug;71(8):6094-9 PMID: 9223503
  38. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.
    J Virol. 1997 Oct;71(10):7895-902 PMID: 9311879
  39. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family.
    Virology. 1997 Nov 24;238(2):305-15 PMID: 9400603
  40. Features of the SIVmac transmembrane glycoprotein cytoplasmic domain that are important for Env functions.
    AIDS Res Hum Retroviruses. 1998 Mar 20;14(5):373-83 PMID: 9546796
  41. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.
    J Biol Chem. 1998 Jun 19;273(25):15773-8 PMID: 9624176
  42. Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis.
    Virology. 1998 Dec 5;252(1):9-16 PMID: 9875311
  43. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    J Virol. 1999 Feb;73(2):1350-61 PMID: 9882340
  44. Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys.
    AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):11-21 PMID: 10024048
  45. Complex determinants of macrophage tropism in env of simian immunodeficiency virus.
    J Virol. 1992 Apr;66(4):2067-75 PMID: 1548752
  46. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    J Virol. 1992 Jun;66(6):3306-15 PMID: 1583717
  47. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
    J Virol. 1992 Jun;66(6):3971-5 PMID: 1583738
  48. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product.
    Virology. 1992 Jul;189(1):167-77 PMID: 1604808
  49. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
    Virology. 1992 Aug;189(2):695-714 PMID: 1386485
  50. Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF.
    Curr Biol. 1999 Nov 4;9(21):1271-4 PMID: 10556093
  51. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.
    J Virol. 2000 Jul;74(13):5836-44 PMID: 10846063
  52. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.
    J Virol. 2000 Dec;74(24):11717-23 PMID: 11090171
  53. In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.
    J Virol. 2001 Jan;75(1):278-91 PMID: 11119598
  54. The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis.
    Traffic. 2000 Aug;1(8):661-74 PMID: 11208154
  55. Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor.
    J Virol. 2002 Jan;76(1):327-37 PMID: 11739697
  56. Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.
    Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14877-82 PMID: 11752436
  57. Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.
    J Virol. 1999 Aug;73(8):7050-5 PMID: 10400808
  58. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Virology. 2001 Nov 10;290(1):59-73 PMID: 11883006
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-07-00
Pages
6775-85
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC421677
Subset
IM
Grants
NIAID NIH HHS · AI50421 · United States
NCRR NIH HHS · RR00168 · United States
NIAID NIH HHS · AI35365 · United States
NCRR NIH HHS · P51 RR000168 · United States
NCRR NIH HHS · K26 RR000168 · United States
NIAID NIH HHS · R01 AI050421 · United States
PHS HHS · R01 40880 · United States
NIAID NIH HHS · P01 AI035365 · United States
NIAID NIH HHS · U01 AI035365 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com